Role of Adiponectin in Coronary Heart Disease Risk
暂无分享,去创建一个
Jon White | Debbie A. Lawlor | D. Lawlor | B. Horta | A. Barros | M. Borges | Jon White | Bernardo Lessa Horta | Cesar de Oliveira | Maria Carolina Borges | Aluísio J.D. Barros | C. de Oliveira | C. D. de Oliveira
[1] Tanya M. Teslovich,et al. Discovery and refinement of loci associated with lipid levels , 2013, Nature Genetics.
[2] Christian Gieger,et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk , 2010, Nature Genetics.
[3] E. Ding,et al. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. , 2009, JAMA.
[4] F. Potier,et al. What is known , 2003 .
[5] Christian Gieger,et al. Common Variants at 10 Genomic Loci Influence Hemoglobin A1C Levels via Glycemic and Nonglycemic Pathways , 2010, Diabetes.
[6] Eric J Tchetgen Tchetgen,et al. Methodological Challenges in Mendelian Randomization , 2014, Epidemiology.
[7] A. Butterworth,et al. Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data , 2013, Genetic epidemiology.
[8] Brian A Ference,et al. Clinical Effect of Naturally Random Allocation to Lower Systolic Blood Pressure Beginning Before the Development of Hypertension , 2014, Hypertension.
[9] Stephen Burgess,et al. Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants , 2016, Epidemiology.
[10] Hynek Pikhart,et al. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials , 2015, The Lancet.
[11] Tamara S. Roman,et al. New genetic loci link adipose and insulin biology to body fat distribution , 2014, Nature.
[12] Nuala A Sheehan,et al. Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome , 2015, Statistics in medicine.
[13] Ross M. Fraser,et al. Genetic studies of body mass index yield new insights for obesity biology , 2015, Nature.
[14] P. Visscher,et al. Calculating statistical power in Mendelian randomization studies. , 2013, International journal of epidemiology.
[15] S. Kihara,et al. Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages , 2001, Circulation.
[16] Mark I. McCarthy,et al. Mendelian Randomization Studies Do Not Support a Causal Role for Reduced Circulating Adiponectin Levels in Insulin Resistance and Type 2 Diabetes , 2013, Diabetes.
[17] Alessandro Pontillo,et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. , 2003, JAMA.
[18] L. Kappelle,et al. Adiponectin and incident coronary heart disease and stroke. A systematic review and meta‐analysis of prospective studies , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[19] P. Scherer,et al. Adiponectin: Just Along for the Ride? , 2016, Circulation research.
[20] J. Danesh,et al. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data , 2011, BMJ : British Medical Journal.
[21] J. Danesh,et al. Large-scale association analysis identifies new risk loci for coronary artery disease , 2013 .
[22] T. Saruta,et al. Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population. , 2004, The Journal of clinical endocrinology and metabolism.
[23] P. Whincup,et al. High adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: does NT-proBNP help to explain this association? , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[24] Eugene Kim,et al. Association between adiponectin levels and coronary heart disease and mortality: a systematic review and meta-analysis. , 2013, International journal of epidemiology.
[25] D. Lawlor,et al. Clustered Environments and Randomized Genes: A Fundamental Distinction between Conventional and Genetic Epidemiology , 2007, PLoS medicine.
[26] Wei Li,et al. Serum total adiponectin level and the risk of cardiovascular disease in general population: a meta-analysis of 17 prospective studies. , 2013, Atherosclerosis.
[27] Bengt Sennblad,et al. Sex-Specific Effects of Adiponectin on Carotid Intima-Media Thickness and Incident Cardiovascular Disease , 2015, Journal of the American Heart Association.
[28] M. Sowers,et al. Adipocytokine and ghrelin levels in relation to cardiovascular disease risk factors in women at midlife: longitudinal associations , 2008, International Journal of Obesity.
[29] P. Scherer,et al. Adiponectin: mechanistic insights and clinical implications , 2012, Diabetologia.
[30] N. Timpson,et al. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors , 2015, European Journal of Epidemiology.
[31] Karen L. Mohlke,et al. Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals , 2012, PLoS genetics.
[32] S. Ebrahim,et al. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.
[33] G. Davey Smith,et al. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.
[34] T Nakamura,et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.
[35] B. Zhang,et al. Serum total adiponectin level and risk of cardiovascular disease in Han Chinese populations: a meta‐analysis of 17 case–control studies , 2012, Clinical endocrinology.
[36] D. Absher,et al. Design of the Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: A Genome-Wide Association Meta-analysis Involving More Than 22 000 Cases and 60 000 Controls , 2010, Circulation. Cardiovascular genetics.
[37] E. Ingelsson,et al. Evidence of a Causal Relationship Between Adiponectin Levels and Insulin Sensitivity , 2013, Diabetes.
[38] P. Froguel,et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions , 2007, Nature Medicine.
[39] F. Dudbridge,et al. Re: "Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects". , 2015, American journal of epidemiology.
[40] S. Thompson,et al. Multivariable Mendelian Randomization: The Use of Pleiotropic Genetic Variants to Estimate Causal Effects , 2015, American journal of epidemiology.
[41] Jie Cao,et al. Adiponectin Levels and Risk of Coronary Heart Disease: A Meta-analysis of Prospective Studies , 2013, The American journal of the medical sciences.
[42] S. Yusuf,et al. Causal Relationship between Adiponectin and Metabolic Traits: A Mendelian Randomization Study in a Multiethnic Population , 2013, PloS one.
[43] Mark Woodward,et al. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies , 2012 .
[44] Florian Kronenberg,et al. The shared allelic architecture of adiponectin levels and coronary artery disease. , 2013, Atherosclerosis.
[45] N. Mehta. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. , 2011, Circulation. Cardiovascular genetics.
[46] Tom R. Gaunt,et al. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials , 2015, The Lancet.